Spironolactone treatment for dermatologic indications is not associated with hypotension in a single-center retrospective study - 14/05/24
Doi : 10.1016/j.jaad.2024.01.057
Rachel C. Hill, BS a, Yu Wang, MD b, Bilal Shaikh, MS c, Michael Ong, BS a, Paul J. Christos, DrPH c, Shari R. Lipner, MD, PhD d, ⁎ 
a Weill Cornell Medical College, New York, New York
b Department of Dermatology, Wake Forest School of Medicine, Wake Forest, North Carolina
c Division of Biostatistics, Department of Population Health Sciences, Weill Cornell Medicine, New York, New York
d Department of Dermatology, Weill Cornell Medicine, New York, New York
∗Correspondence to: Shari R. Lipner, MD, PhD, Department of Dermatology, Weill Cornell Medicine, 1305 York Ave, New York, NY 10021Department of DermatologyWeill Cornell Medicine1305 York AveNew YorkNY10021
Key words : acne, blood pressure monitoring, dermatology, hair loss, hirsutism, hypotension, medical dermatology, spironolactone
| Funding sources: This investigation was supported by the National Center for Advancing Translational Sciences (NCATS) grant # UL1-TR-002384 of the Clinical and Translational Science Center at Weill Cornell Medical College. |
|
| Financial disclosures: Dr Lipner has served as a consultant for Ortho-Dermatologics, Eli Lilly, Moberg Pharmaceuticals, and BelleTorus Corporation. |
|
| Patient consent: Not applicable. |
|
| IRB approval status: Reviewed and approved by Weill Cornell Medicine IRB; protocol # 19-11021077. |
© 2024
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 90 - N° 6
P. 1245-1247 - juin 2024 Retour au numéro
Article précédent
- Outcomes of cutaneous surgery for nonmelanoma skin cancer in patients with different Fitzpatrick skin types: A nationwide, multicenter, prospective study
- Umer Nadir, Michael D. Yi, Eric Koza, Victoria J. Shi, Loma Dave, Farhana Ikmal Hisham, Amanda Maisel-Campbell, Katherine A. Lin, Sarah A. Ibrahim, Bianca Y. Kang, Noor Anvery, McKenzie A. Dirr, Rachel E. Christensen, Julia M. Riley, Roopal V. Kundu, Juliet L. Aylward, Omar Bari, Hamza Bhatti, Diana Bolotin, Basil S. Cherpelis, Joel L. Cohen, Sean Condon, Sheila Farhang, Bahar Firoz, Algin B. Garrett, Roy G. Geronemus, Nicholas J. Golda, Tatyana R. Humphreys, Eva A. Hurst, Oren H. Jacobson, Shang Brian Jiang, Pritesh S. Karia, Arash Kimyai-Asadi, David J. Kouba, Martha Laurin Council, Marilyn Le, Deborah F. MacFarlane, Ian A. Maher, Stanley J. Miller, Eduardo K. Moioli, Meghan Morrow, Julia Neckman, Samuel R. Peterson, Christine Poblete-Lopez, Chad L. Prather, Jennifer S. Ranario, Ashley G. Rubin, Andrew M. Swanson, Christopher Urban, Yaohui (Gloria) Xu, Ross Pearlman, Brian A. Cahn, Dermbase Research Group, Simon Yoo, Vishnu Harikumar, Alexandra Weil, Matthew Schaeffer, Sanjana Iyengar, Emily Poon, Murad Alam
- Combination therapy with imiquimod and 5-fluorouracil cream for the treatment of actinic keratoses, a prospective open-label nonrandomized uncontrolled pilot trial
- Richard Maxwell Regester, Amy C. Cannella, Julianna Hirz, Brian Sayles, Stacie Schlange, Amy Rau, Harlan R. Sayles, Anthony J. Griess
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?